SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection.

Tsiftsoglou, Stefanos A

Tsiftsoglou, Stefanos A.

Tsiftsoglou SA; Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece. Electronic address: stefanos.tsiftsoglou@gmail.com.

Mol Immunol ; 135: 421-425, 2021 07.

Article in English | MEDLINE | ID: covidwho-1157620

Subject(s)

COVID-19; Complement Pathway, Alternative/genetics; Complement System Proteins; Genetic Variation; SARS-CoV-2/immunology; COVID-19/genetics; COVID-19/immunology; Complement System Proteins/genetics; Complement System Proteins/immunology; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Genetic Variation / Complement System Proteins / Complement Pathway, Alternative / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Variants Limits: Humans Language: English Journal: Mol Immunol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google